Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$50,794
-$76,803 QoQ
Shares Held
200
-61.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,615
of 4,676 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,828,584
PutShares
7,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CREDIT INDUSTRIEL ET COMMERCIAL holds $13,872,333 across 6 Drug Manufacturers - General names. JNJ ranks #6 (0.4% of the industry book) .
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,828,584 | 7,200 | Put | Defined | 2026-07-24 | |
| 2026-06-30 | $50,794 | 200 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $1,759,968 | 7,200 | Put | Defined | 2026-04-29 | |
| 2026-03-31 | $127,597 | 522 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $286,832 | 1,386 | Shares | Defined | 2026-02-03 | |
| 2025-12-31 | $1,490,040 | 7,200 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $1,001,268 | 5,400 | Put | Defined | 2025-11-07 | |
| 2025-09-30 | $419,234 | 2,261 | Shares | Defined | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||